May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Clinical Presentation, Management and Outcomes of Thygeson’s Superficial Punctate Keratitis in the UK
Author Affiliations & Notes
  • S. A. Issa
    Ophthalmology, Royal Victoria Infirmary, Newcastle Upon Tyne, United Kingdom
  • K. Aye
    Ophthalmology, Royal Victoria Infirmary, Newcastle Upon Tyne, United Kingdom
  • S. Manvikar
    Ophthalmology, Royal Victoria Infirmary, Newcastle Upon Tyne, United Kingdom
  • F. Figueiredo
    Ophthalmology, Royal Victoria Infirmary, Newcastle upon tyne, United Kingdom
  • Footnotes
    Commercial Relationships  S.A. Issa, None; K. Aye, None; S. Manvikar, None; F. Figueiredo, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 2377. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. A. Issa, K. Aye, S. Manvikar, F. Figueiredo; Clinical Presentation, Management and Outcomes of Thygeson’s Superficial Punctate Keratitis in the UK. Invest. Ophthalmol. Vis. Sci. 2008;49(13):2377. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To describe presentation, management and outcomes of Thygeson’s Superficial Punctate Keratitis (TSPK) in UK.

Methods: : A retrospective review of consecutive cases of TSPK which presented to the Ocular Surface Service from Sep1998 to Nov 2007.

Results: : Twenty cases were studied (14 females: 6 males). Age at presentation had a mean of 39.9 years (range; 5 - 72). Both eyes were affected in 18 (90%) cases. In two female cases only one eye was affected. Average follow up was 41 months (range; 2 - 115). Right and left best corrected visual acuities improved after topical treatment from a LogMAR equivalent of 0.18 to 0.06 and 0.13 to 0.05 respectively. We divided the cases into three groups according to treatment. Group 1: Female patients (n=2) ages 37 and 52 were managed by topical lubricants only. TSPK resolved and both patients had no recurrence. Group 2: Patients were managed with topical steroid (mean age; 45 years). There were two males and four females. The youngest patient was 5 years old. He needed a bandage contact lens which was more effective as it was difficult to instil drops in his eyes. Four patients had a short course of TSPK (2 - 24 months) and did not have recurrences after stopping topical steroids. One patient had a long course (43 months) and had three recurrences after stopping the steroid drops but eventually did not need treatment. Group 3: Patients (n=12) were initially started on topical steroid but had significant recurrences after stopping it. These patients were given topical cyclosporine-A (CsA) 2% eye drop on alternate days and a reducing dose of topical steroids (eventually stopped). The mean age was 36.5 years (4 males and 8 females). The period between starting steroid and CsA treatment ranged from 3 months to 7 years (mean; 18 months). Six of the 12 patients were able to stop CsA without recurrences (duration of treatment: 12 - 56 months). The remaining 6 patients needed long term low dose CsA to prevent recurrences and stayed on it once or twice a week. Some patients complained of stinging after instilling CsA, however there were no other significant side effects.

Keywords: keratitis • cyclosporine • corticosteroids 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×